75,000 cases of eye care products just got recalled: Here's to know, plus what to buy instead
If you suffer from dry or itchy eyes, listen up: more than 75,000 cases of eye drop solution were voluntarily recalled nationwide by BRS Analytical Service, a pharmaceutical testing lab, according to an enforcement report from the Food and Drug Administration. AvKare, a manufacturer of medical, surgical and pharmaceutical items, originally reported the recall.
Why are certain eye care products being recalled?
The recall follows an FDA audit at BRS Analytical Service, which found a number of Current Good Manufacturing Practice (cGMP) deviations. The cGMP is a set of regulations enforced by the FDA to ensure that manufacturers use safe practices to produce pharmaceutical products. 'cGMP deviations may lead to products of unacceptable quality, and it is not possible to rule out patient risks resulting from use of these products,' according to the statement from AvKare.
Additionally, the enforcement report says the reason for the recall is 'due to a lack of assurance to sterility.' The recalled products, also described as 'eye lubricants,' help relieve dry and irritated eyes.
What products are part of the recall?
The recall encompasses ophthalmic solutions shipped over a two year period from: May 26, 2023 until April 21, 2025, according to AvKare. If you have any of the below items, you should stop using them immediately:
NDC# 50268-043-15 Artificial Tears Ophthalmic Solution
NDC# 50268-066-15 Carboxymethylcellulose Sodium Ophthalmic Gel 1%
NDC# 50268-068-15 Carboxymethylcellulose Sodium Ophthalmic Solution
NDC# 50268-126-15 Lubricant Eye Drops Solution
NDC# 50268-678-15 Polyvinyl Alcohol Ophthalmic Solution
What should you do?
In addition to pausing any use of the above compromised products, you can follow the steps below and swap in one of our expert-approved alternatives.
If you have any of the recalled products, or think you may have any of them, AvKare is encouraging consumers to fill out a Recall Form and email it to them. After sending in the form, the organization will then send you a Return Authorization Form, which you can use to send the products into the following address with the package marked: Ophthalmic RECALL. They will also issue full credit including shipping costs for returns.
R&S Northeast LLC
8407 Austin Tracy Rd
Fountain Run, KY 42133
Expert-recommended alternatives to use instead
If you suffer from dry, itchy or irritated eyes, experts recommend using the following methods to help alleviate symptoms. To treat aqueous dry eye, also known as blepharitis, it's best to use a warm compress over the eyes for about 30 seconds daily, according to Dr. Yuna Rapaport, a board-certified ophthalmologist at Manhattan Eye. Additionally, 'humidity in the bedroom is also helpful for evaporative dry eye,' says Rapaport. Consider using a humidifier in your room to help alleviate symptoms.
Ocusoft
These cleansing eyelid pads also come recommended by Rapoport to help with dry eyes. The set includes 35 fragrance- and alcohol-free pads that help remove makeup, pollen and oils that can irritate the eyes, according to the brand.
Eye Revive by Daily Practice
Rapaport recommends this foaming cleanser to help hydrate and soothe eyelids. It has glycerin, a humectant that hydrates skin by pulling moisture from the air, and fruit extracts with antioxidants, like lycopene, that can help prevent skin damage from free radicals, according to the brand. Rapaport says to use the cleanser by gently scrubbing over and around the eyelids. She also recommends applying the solution to a cotton pad and washing the inner and outer corners of the eyes.
A warm compress can also be a great alternative for soothing irritated eyes, according to Rapaport. This compress, which has a 4.5-star average rating from 1,745 reviews on Amazon, has 30 self-heating eye compresses to relieve dry eyes, reduce eyelid inflammation and unblock glands in the eyes, according to the brand. Since they're self-heating you don't need to put them in the microwave and risk them getting too hot. You can also use your FSA funds to purchase these.
Levoit Humidifier
A humidifier also helps relieve dry eyes by adding moisture to an environment, like your bedroom. This 2.5-liter option has an auto shut-off feature and is BPA free. Humidifiers are great to have around especially if you have allergies and regularly get irritated eyes or experience dryness or allergies.
Meet our expert
At NBC Select, we work with experts who have specialized knowledge and authority based on relevant training and/or experience. We also take steps to ensure all expert advice and recommendations are made independently and without undisclosed financial conflicts of interest.
Why trust NBC Select?
I'm a commerce editor at NBC Select, where I write about deals and sale events, product reviews and roundups and articles on product recalls. I reviewed a statement issued by AvKare and researched documents from the FDA as well as spoke with a board-certified ophthalmologist for this story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
11 hours ago
- The Independent
Supreme court widens court options for vaping companies pushing back against FDA rules
The Supreme Court sided with e-cigarette companies on Friday in a ruling making it easier to sue over Food and Drug Administration decisions blocking their products from the multibillion-dollar vaping market. The 7-2 opinion comes as companies push back against a yearslong federal regulatory crackdown on electronic cigarettes. It's expected to give the companies more control over which judges hear lawsuits filed against the agency. The justices went the other way on vaping in an April decision, siding with the FDA in a ruling upholding a sweeping block on most sweet-flavored vapes instituted after a spike in youth vaping. The current case was filed by R.J. Reynolds Vapor Co., which had sold a line of popular berry and menthol-flavored vaping products before the agency started regulating the market under the Tobacco Control Act in 2016. The agency refused to authorize the company's Vuse Alto products, an order that 'sounded the death knell for a significant portion of the e-cigarette market,' Justice Amy Coney Barrett wrote in the majority opinion. The company is based in North Carolina and typically would have been limited to challenging the FDA in a court there or in the agency's home base of Washington. Instead, it joined forces with Texas businesses that sell the products and sued there. The conservative 5th U.S. Circuit Court of Appeals allowed the lawsuit to go forward, finding that anyone whose business is hurt by the FDA decision can sue. The agency appealed to the Supreme Court, arguing that R.J. Reynolds was trying to find a court friendly to its arguments, a practice often called 'judge shopping." The justices, though, found that the law does allow other businesses affected by the FDA decisions, like e-cigarette sellers, to sue in their home states. In a dissent, Justice Ketanji Brown Jackson, joined by Justice Sonia Sotomayor, said she would have sided with the agency and limited where the cases can be filed. The Campaign for Tobacco-Free Kids called the majority decision disappointing, saying it would allow manufacturers to 'judge shop,' though it said the companies will still have to contend with the Supreme Court's April decision. Attorney Ryan Watson, who represented R.J. Reynolds, said that the court recognized that agency decisions can have devastating downstream effects on retailers and other businesses, and the decision 'ensures that the courthouse doors are not closed' to them. ___ Follow the AP's coverage of the Supreme Court at
Reuters
3 days ago
- Reuters
U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
June 18 - A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge brought by compounding pharmacies who sought to continue making copies of the drugs.
Reuters
4 days ago
- Reuters
US FDA to shorten review time for drug developers under new voucher program
June 17 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it is launching a program under which its commissioner can issue vouchers to companies to shorten their review time for a drug application to 1-2 months from the typical timeline of about 10-12 months. The new Commissioner's National Priority Voucher (CNPV) program convenes experts from the regulator's offices for a team-based review, instead of using the standard review system, where a drug application is sent to numerous FDA offices, the agency said. The FDA plans to give a limited number of vouchers to companies aligned with U.S. national priorities in the first year of the program. The new program aims to accelerate the drug review process while maintaining the FDA's rigorous standards for safety, efficacy and quality, the regulator said.
